diltiazem has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (47.06) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
| Gustafson, KS; Melemed, A; Sulciner, D; Tolins, JP; Vercellotti, GM | 1 |
| Filep, JG; Földes-Filep, E | 1 |
| Bazill, GW; Dexter, TM | 1 |
| Bevan, J; Glusa, E; Heptinstall, S | 1 |
| Imura, Y; Iwasaki, K; Nishikawa, K; Shibouta, Y; Terashita, Z | 1 |
| Braquet, P; Hosford, D; Koltai, M; Tosaki, A | 1 |
| Braquet, P; Mest, HJ; Meyer, E; Riedel, A | 1 |
| Altman, R; Dujovne, C; Scazziota, A | 1 |
| Braquet, P; Mest, HJ; Riedel, A | 1 |
| Valone, FH | 1 |
| Lad, N; Lunt, DO; McCullagh, KG; Tuffin, DP; Wade, PJ | 1 |
| Alabaster, VA; Cheeseman, HE; Cooper, K; deSouza, RN; Keir, RF; Parry, MJ | 1 |
| Altman, R; Budd, SE; Chernoff, SB; Dollar, LE; Zucker, ML | 1 |
| Diéz Marques, ML; Duque, I; Gonzalez-Rubio, M; Rodriguez Puyol, D; Rodriguez Puyol, M; Ruiz, P | 1 |
| Itoh, M; Joh, T; Katoh, N; Yokoyama, Y | 1 |
| Hanif, S; Khan, FL; Rahman, HB; Rahman, IH; Rasheed, H; Saeed, SA; Shah, BH; Shariff, AH | 1 |
1 trial(s) available for diltiazem and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Arachidonic Acid; Aspirin; Bleeding Time; Blood Platelets; Diltiazem; Drug Synergism; Epinephrine; Female; Humans; Male; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors | 1993 |
16 other study(ies) available for diltiazem and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Calcium channel blockade inhibits platelet activating factor production by human umbilical vein endothelial cells.
Topics: Bradykinin; Cells, Cultured; Diltiazem; Endothelium, Vascular; Humans; Kinetics; Lanthanum; Platelet Activating Factor; Thrombin; Umbilical Veins; Verapamil | 1991 |
Inhibition by calcium channel blockers of the binding of platelet-activating factor to human neutrophil granulocytes.
Topics: Binding, Competitive; Calcium Channel Blockers; Cytoplasmic Granules; Diltiazem; Granulocytes; Humans; In Vitro Techniques; Indicators and Reagents; Kinetics; Neutrophils; Platelet Activating Factor; Superoxides; Verapamil | 1990 |
Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Survival; Chloroquine; Diltiazem; Drug Synergism; Endocytosis; Furans; Humans; Hydroxyzine; In Vitro Techniques; Leukemia, Myeloid; Mice; Nifedipine; Phospholipid Ethers; Platelet Activating Factor; Pyridines; Quinidine; Quinine; Sodium Fluoride; Thiazoles; Triazoles; Verapamil | 1990 |
Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation.
Topics: Adenosine Diphosphate; Amlodipine; Calcium Channel Blockers; Collagen; Diltiazem; Epinephrine; Humans; In Vitro Techniques; Nifedipine; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Serotonin Antagonists; Verapamil | 1989 |
Endothelin-induced sudden death and the possible involvement of platelet activating factor (PAF).
Topics: Animals; Aspirin; Azepines; Blood Pressure; Death, Sudden; Dexamethasone; Diltiazem; Electrocardiography; Endothelins; Guinea Pigs; Hypertension; Hypotension; Male; Mice; Mice, Inbred ICR; Peptides; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Triazines; Triazoles | 1989 |
Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusion.
Topics: Animals; Arrhythmias, Cardiac; Diltiazem; Diterpenes; Ginkgolides; Heart Function Tests; Lactones; Male; Metoprolol; Myocardial Reperfusion; Perfusion; Platelet Activating Factor; Rats; Rats, Inbred Strains; Reperfusion Injury | 1989 |
The arrhythmogenic effect of platelet activating factor (PAF) is inhibited by PAF antagonist and by substances influencing eicosanoids.
Topics: Aconitic Acid; Animals; Arrhythmias, Cardiac; Diazepam; Diltiazem; Dogs; Guinea Pigs; Imidazoles; Myocardial Contraction; Naphthalenes; Ouabain; Platelet Activating Factor; Pyrimidines; Rats; Reference Values; Trapidil | 1988 |
Diltiazem potentiates the inhibitory effect of aspirin on platelet aggregation.
Topics: Arachidonic Acids; Aspirin; Diltiazem; Drug Synergism; Female; Humans; Male; Platelet Activating Factor; Platelet Aggregation; Time Factors | 1988 |
The effect of the specific PAF antagonist BN 52021 and the calcium blocker diltiazem on PAF induced arrhythmogenicity.
Topics: Administration, Oral; Animals; Arrhythmias, Cardiac; Diltiazem; Diterpenes; Ginkgolides; Guinea Pigs; In Vitro Techniques; Injections, Intravenous; Lactones; Ouabain; Platelet Activating Factor | 1987 |
Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers.
Topics: Adult; Blood Platelets; Calcium Channel Blockers; Diltiazem; Humans; Platelet Activating Factor; Platelet Aggregation; Protein Binding; Verapamil | 1987 |
Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human platelets.
Topics: Benzazepines; Blood Platelets; Buffers; Calcium; Calcium Channel Blockers; Diltiazem; Humans; Male; Nifedipine; Platelet Activating Factor; Platelet Aggregation; Statistics as Topic; Stereoisomerism; Tritium; Verapamil | 1986 |
Pharmacological profile of UK-74,505, a novel and selective PAF antagonist with potent and prolonged oral activity.
Topics: Administration, Oral; Animals; Aorta; Azepines; Blood Platelets; Brain; Calcium Channels, L-Type; Capillary Permeability; Cattle; Dihydropyridines; Diltiazem; Gallopamil; Guinea Pigs; Hypotension; Imidazoles; In Vitro Techniques; Kinetics; Male; Membranes; Mice; Mice, Inbred Strains; Muscle Contraction; Muscle Proteins; Nitrendipine; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Potassium Chloride; Rabbits; Rats; Rats, Sprague-Dawley; Skin; Triazoles; Tritium | 1994 |
Calcium channel blockers inhibit hydrogen peroxide-induced proliferation of cultured rat mesangial cells.
Topics: Animals; Calcium Channel Blockers; Cell Count; Cell Division; Cells, Cultured; Diltiazem; Diterpenes; Ginkgolides; Glomerular Mesangium; Hydrogen Peroxide; Kinetics; Lactones; Platelet Activating Factor; Platelet-Derived Growth Factor; Rats; Rats, Wistar; Thrombin; Thymidine; Tritium; Verapamil | 1993 |
[Evaluation of the mechanism of endothelin-induced rat gastric mucosal lesion formation].
Topics: Animals; Calcium; Chromones; Diltiazem; Endothelins; Gastric Mucosa; Leukotrienes; Male; Phospholipid Ethers; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; SRS-A | 1994 |
Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine.
Topics: Diltiazem; Dose-Response Relationship, Drug; Drug Synergism; Estrenes; Flavonoids; Humans; In Vitro Techniques; Indomethacin; Kinetics; Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Pyrrolidinones; Serotonin; Thromboxane A2; Verapamil | 2001 |